Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debbie Hicks

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2019
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.
Journal of Diabetes|October 7, 2010
Results and analysis of the 2008-2009 Insulin Injection Technique Questionnaire surveyCarina De Coninck, Anders Frid, Ruth Gaspar, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2022
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical PracticeMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2020
Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related ComplicationsMarc Evans, Angharad R Morgan, Dipesh Patel, et al.
The Lancet. Oncology|November 6, 2018
Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trialTobias Goschzik, Edward C Schwalbe, Debbie Hicks, et al.
Neuro-Oncology Advances|July 1, 2024
In vivo modeling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastomaJemma Castle, Gary Shaw, Dominic Weller, et al.
Human Molecular Genetics|December 17, 2013
Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathyDebbie Hicks, Golara Torabi Farsani, Steven Laval, et al.
Oncotarget|October 1, 2015
Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trialSteven C Clifford, Birgitta Lannering, Ed C Schwalbe, et al.
Mayo Clinic Proceedings|September 6, 2016
New Insulin Delivery RecommendationsAnders H Frid, Gillian Kreugel, Giorgio Grassi, et al.
Journal of Neurosurgery. Pediatrics|January 18, 2020
Effects of the growth pattern of medulloblastoma on short-term neurological impairments after surgery: results from the prospective multicenter HIT-SIOP PNET 4 studyElizabeth Schepke, Magnus Tisell, Colin Kennedy, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2019
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into PracticeAmar Ali, Steve Bain, Debbie Hicks, et al.
Journal of Diabetes|October 7, 2010
Results and analysis of the 2008-2009 Insulin Injection Technique Questionnaire surveyCarina De Coninck, Anders Frid, Ruth Gaspar, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 19, 2022
Meeting the Challenge of Virtual Diabetes Care: A Consensus Viewpoint on the Positioning and Value of Oral Semaglutide in Routine Clinical PracticeMarc Evans, Angharad R Morgan, Stephen C Bain, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|November 15, 2020
Risk Prediction of the Diabetes Missing Million: Identifying Individuals at High Risk of Diabetes and Related ComplicationsMarc Evans, Angharad R Morgan, Dipesh Patel, et al.
The Lancet. Oncology|November 6, 2018
Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trialTobias Goschzik, Edward C Schwalbe, Debbie Hicks, et al.
Neuro-Oncology Advances|July 1, 2024
In vivo modeling recapitulates radiotherapy delivery and late-effect profile for childhood medulloblastomaJemma Castle, Gary Shaw, Dominic Weller, et al.
Human Molecular Genetics|December 17, 2013
Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathyDebbie Hicks, Golara Torabi Farsani, Steven Laval, et al.
Oncotarget|October 1, 2015
Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trialSteven C Clifford, Birgitta Lannering, Ed C Schwalbe, et al.
Mayo Clinic Proceedings|September 6, 2016
New Insulin Delivery RecommendationsAnders H Frid, Gillian Kreugel, Giorgio Grassi, et al.
Journal of Neurosurgery. Pediatrics|January 18, 2020
Effects of the growth pattern of medulloblastoma on short-term neurological impairments after surgery: results from the prospective multicenter HIT-SIOP PNET 4 studyElizabeth Schepke, Magnus Tisell, Colin Kennedy, et al.
Pageof 6